Meta Healthcare has entered into a regional licensing collaboration to support commercialisation of MetaCore Tyrosinaemia across the Middle East and North Africa. MetaCore Tyrosinaemia is a medical nutrition product designed to support the dietary management of tyrosinaemia type 1.
Why MENA
Rare metabolic disorders, including tyrosinaemia, can present higher prevalence in regions with greater frequency of consanguineous unions. Local specialist clinical networks and regulatory expertise are decisive for successful commercialisation.
- Territorial scope: MENA region
- Structure: regional licensing collaboration
- Retained territories: United Kingdom and EU
The collaboration reflects Meta Healthcare’s development model — pursuing differentiated specialised products with retained long-term value in core territories, while working with regional partners where local expertise is decisive.
Availability of MetaCore Tyrosinaemia varies by territory and is subject to local regulatory and reimbursement processes. Use should be supervised by a registered metabolic dietitian or healthcare professional.